-
EP3615079
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3615079
| EP3615079 - STABLE CANNABINOID FORMULATIONS [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 15.07.2024 Database last updated on 31.08.2024 | |
| Former | Grant of patent is intended Status updated on 19.12.2023 | ||
| Former | Examination is in progress Status updated on 18.10.2023 | ||
| Former | Grant of patent is intended Status updated on 06.03.2023 | ||
| Former | Examination is in progress Status updated on 29.07.2022 | ||
| Former | Request for examination was made Status updated on 31.01.2020 | ||
| Former | The international publication has been made Status updated on 02.11.2018 | Most recent event Tooltip | 20.07.2024 | New entry: Decision on request for further processing | Applicant(s) | For all designated states Radius Pharmaceuticals, Inc. 22 Boston Wharf Road, 7th Floor Boston, MA 02210 / US | [2023/16] |
| Former [2020/33] | For all designated states Fresh Cut Development, LLC 444 South Ellis Street Chandler AZ 85286 / US | ||
| Former [2020/19] | For all designated states Fresh Cut Development, LLC 444 South Ellis Road Chandler, AZ 85286 / US | ||
| Former [2020/10] | For all designated states Insys Development Company, Inc. 1333 South Spectrum Boulevard Suite 100 Chandler, AZ 85286 / US | Inventor(s) | 01 /
VANGARA, Kiran, Kumar 1333 South Spectrum Blvd. Suite 100 Chandler, AZ 85286 / US | 02 /
LI, Huaguang 1333 South Spectrum Blvd. Suite 100 Chandler, AZ 85286 / US | 03 /
YAN, Ningxin 1333 South Spectrum Blvd. Suite 100 Chandler, AZ 85286 / US | 04 /
NGUYEN, Hung Q. 1333 South Spectrum Blvd. Suite 100 Chandler, AZ 85286 / US | 05 /
GOSKONDA, Venkat, R. 1333 South Spectrum Blvd. Suite 100 Chandler, AZ 85286 / US | [2020/10] | Representative(s) | Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB | [N/P] |
| Former [2020/10] | Elkington and Fife LLP Prospect House 8 Pembroke Road Sevenoaks, Kent TN13 1XR / GB | Application number, filing date | 17907335.8 | 22.09.2017 | [2020/10] | WO2017US52897 | Priority number, date | US201715499178 | 27.04.2017 Original published format: US201715499178 | [2020/10] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2018200024 | Date: | 01.11.2018 | Language: | EN | [2018/44] | Type: | A1 Application with search report | No.: | EP3615079 | Date: | 04.03.2020 | Language: | EN | The application published by WIPO in one of the EPO official languages on 01.11.2018 takes the place of the publication of the European patent application. | [2020/10] | Search report(s) | International search report - published on: | US | 01.11.2018 | (Supplementary) European search report - dispatched on: | EP | 26.08.2020 | Classification | IPC: | A61K47/14, A61K31/05, A61K47/10, A61K47/44, A61P3/00, A61P3/04, A61P25/08 | [2020/39] | CPC: |
A61K9/0053 (EP);
A61K31/05 (EP);
A61K47/10 (EP);
A61K47/14 (EP);
A61K47/44 (EP);
A61K9/08 (EP);
| C-Set: |
A61K31/05, A61K2300/00 (EP)
|
| Former IPC [2020/10] | A61K47/14, A61K9/00, A61K31/05 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2020/10] | Title | German: | STABILE CANNABINOIDFORMULIERUNGEN | [2020/10] | English: | STABLE CANNABINOID FORMULATIONS | [2020/10] | French: | FORMULATIONS DE CANNABINOÏDES STABLES | [2020/10] | Entry into regional phase | 26.11.2019 | National basic fee paid | 26.11.2019 | Search fee paid | 26.11.2019 | Designation fee(s) paid | 26.11.2019 | Examination fee paid | Examination procedure | deleted | Communication of intention to grant the patent | 26.11.2019 | Examination requested [2020/10] | 14.07.2021 | Amendment by applicant (claims and/or description) | 02.08.2022 | Despatch of a communication from the examining division (Time limit: M06) | 19.12.2022 | Reply to a communication from the examining division | 07.03.2023 | Communication of intention to grant the patent | 18.10.2023 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 20.12.2023 | Communication of intention to grant the patent | 15.05.2024 | Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time | 15.07.2024 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | Request for further processing for: | The application is deemed to be withdrawn due to failure to fulfill actions required for granting the patent | 15.07.2024 | Request for further processing filed | 15.07.2024 | Full payment received (date of receipt of payment) Request granted | 19.07.2024 | Decision despatched | The application is deemed to be withdrawn due to failure to fulfill actions required for granting the patent | 18.10.2023 | Request for further processing filed | 18.10.2023 | Full payment received (date of receipt of payment) Request granted | 26.10.2023 | Decision despatched | The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report | 14.07.2021 | Request for further processing filed | 14.07.2021 | Full payment received (date of receipt of payment) Request granted | 23.07.2021 | Decision despatched | The application is deemed to be withdrawn due to failure to indicate the wish to proceed further with the application | 14.07.2021 | Request for further processing filed | 14.07.2021 | Full payment received (date of receipt of payment) Request granted | 23.07.2021 | Decision despatched | Fees paid | Renewal fee | 26.11.2019 | Renewal fee patent year 03 | 14.09.2020 | Renewal fee patent year 04 | 15.09.2021 | Renewal fee patent year 05 | 28.09.2022 | Renewal fee patent year 06 | 21.03.2024 | Renewal fee patent year 07 | Penalty fee | Additional fee for renewal fee | 30.09.2023 | 07 M06 Fee paid on 21.03.2024 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X]US2015343071 (VANGARA KIRAN KUMAR [US], et al); | [X]US2016271252 (VANGARA KIRAN KUMAR [US], et al); | [X]WO2016191651 (INSYS DEV CO INC [US]); | [X]US2016367496 (VANGARA KIRAN KUMAR [US], et al) | International search | [A]US2006058293 (WEBER ECKARD [US], et al) [A] 1-2, 4-23* Entire Document *; | [Y]US2011262442 (HAMILTON CHARLES P [US], et al) [Y] 20 * Para [0180] *; | [A]US2012172325 (CURRIE MARK G [US]) [A] 1-2, 4-23 * Entire Document *; | [A]US2013210821 (VATH JAMES E [US]) [A] 1-2, 4-23 * Entire Document *; | [XY]US2015342902 (VANGARA KIRAN KUMAR [US], et al) [X] 1-2, 4-19, 21-23 * Para [0020]; Para [0026]; Para [0027]; Para [0050]; Para [0054]; Para [0079]; Para [0082]; Para [0087]; Para [0097]; Para [0120]; Para [0174]; Para [0190]; Para [0201]; Para [0217]; Para [0224]; Table 14; Table 24; Table 25 Claim 14; Example 8 * [Y] 20; | [A] - MITCHELL et al., "Vigabatrin for infantile spasms", Pediatr Neurol., (20020927), vol. 3, pages 161 - 164, XP055527999 [A] 20 * Pg. 1; Abstract * | [A] - SCOPINHO et al., "Cannabidiol inhibits the hyperphagia induced by cannabinoid-1 or serotonin- 1A receptor agonists", Pharmacology, Biochemistry and Behavior, (20110114), vol. 98, pages 268 - 272, XP028168221 [A] 17-18 * , Abstract * DOI: http://dx.doi.org/10.1016/j.pbb.2011.01.007 | by applicant | US2015343071 | US2015342902 | US2016271252 | WO2016191651 | US2016367496 | US19950620044 |